Alexandre Iarkov

645 total citations
17 papers, 483 citations indexed

About

Alexandre Iarkov is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Cognitive Neuroscience. According to data from OpenAlex, Alexandre Iarkov has authored 17 papers receiving a total of 483 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Cellular and Molecular Neuroscience and 7 papers in Cognitive Neuroscience. Recurrent topics in Alexandre Iarkov's work include Nicotinic Acetylcholine Receptors Study (9 papers), Memory and Neural Mechanisms (6 papers) and Neuroscience and Neuropharmacology Research (5 papers). Alexandre Iarkov is often cited by papers focused on Nicotinic Acetylcholine Receptors Study (9 papers), Memory and Neural Mechanisms (6 papers) and Neuroscience and Neuropharmacology Research (5 papers). Alexandre Iarkov collaborates with scholars based in United States, Chile and Colombia. Alexandre Iarkov's co-authors include Valentina Echeverrı́a, George E. Barreto, J. Alex Grizzell, Ranu Jung, Thomas M. Hamm, James J. Abbas, Derek O’Neill, Seung-Jae Kim, Matthew Fairchild and Vadim V. Tarasov and has published in prestigious journals such as Journal of Neurophysiology, IEEE Transactions on Biomedical Engineering and Experimental Neurology.

In The Last Decade

Alexandre Iarkov

17 papers receiving 479 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alexandre Iarkov United States 14 196 142 78 77 66 17 483
Tahereh Ghadiri Iran 13 124 0.6× 127 0.9× 79 1.0× 64 0.8× 76 1.2× 31 473
Sixun Yu China 14 230 1.2× 211 1.5× 100 1.3× 150 1.9× 46 0.7× 31 801
Aihua Pan China 16 221 1.1× 151 1.1× 78 1.0× 37 0.5× 29 0.4× 43 640
Ewelina Pałasz Poland 8 155 0.8× 256 1.8× 109 1.4× 168 2.2× 49 0.7× 17 587
Maria Bellomo Italy 18 326 1.7× 233 1.6× 113 1.4× 77 1.0× 61 0.9× 30 848
Soumyabrata Munshi United States 11 149 0.8× 96 0.7× 81 1.0× 65 0.8× 29 0.4× 16 471
Adrianna Wysocka Poland 5 177 0.9× 224 1.6× 94 1.2× 136 1.8× 41 0.6× 5 566
Martha C. Rivera‐Cervantes Mexico 16 226 1.2× 247 1.7× 126 1.6× 39 0.5× 46 0.7× 24 602
Ivan L. Salazar Portugal 9 280 1.4× 281 2.0× 141 1.8× 39 0.5× 60 0.9× 11 727
Wan Seok Joo South Korea 12 183 0.9× 112 0.8× 29 0.4× 102 1.3× 45 0.7× 13 449

Countries citing papers authored by Alexandre Iarkov

Since Specialization
Citations

This map shows the geographic impact of Alexandre Iarkov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexandre Iarkov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexandre Iarkov more than expected).

Fields of papers citing papers by Alexandre Iarkov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexandre Iarkov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexandre Iarkov. The network helps show where Alexandre Iarkov may publish in the future.

Co-authorship network of co-authors of Alexandre Iarkov

This figure shows the co-authorship network connecting the top 25 collaborators of Alexandre Iarkov. A scholar is included among the top collaborators of Alexandre Iarkov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexandre Iarkov. Alexandre Iarkov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Echeverrı́a, Valentina, et al.. (2023). Nicotinic acetylcholine receptors and learning and memory deficits in Neuroinflammatory diseases. Frontiers in Neuroscience. 17. 1179611–1179611. 17 indexed citations
2.
Iarkov, Alexandre, et al.. (2021). Cholinergic Receptor Modulation as a Target for Preventing Dementia in Parkinson’s Disease. Frontiers in Neuroscience. 15. 665820–665820. 17 indexed citations
3.
Barreto, George E., et al.. (2020). Cotinine Enhances Fear Extinction and Astrocyte Survival by Mechanisms Involving the Nicotinic Acetylcholine Receptors Signaling. Frontiers in Pharmacology. 11. 303–303. 7 indexed citations
4.
Iarkov, Alexandre, George E. Barreto, J. Alex Grizzell, & Valentina Echeverrı́a. (2020). Strategies for the Treatment of Parkinson’s Disease: Beyond Dopamine. Frontiers in Aging Neuroscience. 12. 4–4. 84 indexed citations
5.
Barreto, George E., et al.. (2018). Cotinine Plus Krill Oil Decreased Depressive Behavior, and Increased Astrocytes Survival in the Hippocampus of Mice Subjected to Restraint Stress. Frontiers in Neuroscience. 12. 952–952. 12 indexed citations
6.
Barreto, George E., et al.. (2018). Cotinine: A Therapy for Memory Extinction in Post-traumatic Stress Disorder. Molecular Neurobiology. 55(8). 6700–6711. 15 indexed citations
7.
Iarkov, Alexandre, et al.. (2018). Intranasal Cotinine Plus Krill Oil Facilitates Fear Extinction, Decreases Depressive-Like Behavior, and Increases Hippocampal Calcineurin A Levels in Mice. Molecular Neurobiology. 55(10). 7949–7960. 20 indexed citations
8.
Grizzell, J. Alex, et al.. (2017). Intranasal cotinine improves memory, and reduces depressive-like behavior, and GFAP + cells loss induced by restraint stress in mice. Experimental Neurology. 295. 211–221. 23 indexed citations
9.
Iarkov, Alexandre, et al.. (2016). Post-treatment with cotinine improved memory and decreased depressive-like behavior after chemotherapy in rats. Cancer Chemotherapy and Pharmacology. 78(5). 1033–1039. 29 indexed citations
10.
Barreto, George E., Alexandre Iarkov, & Valentina Echeverrı́a. (2015). Beneficial effects of nicotine, cotinine and its metabolites as potential agents for Parkinson’s disease. Frontiers in Aging Neuroscience. 6. 340–340. 91 indexed citations
11.
Patel, Sagar P., J. Alex Grizzell, Ross Zeitlin, et al.. (2014). Cotinine halts the advance of Alzheimer's disease-like pathology and associated depressive-like behavior in Tg6799 mice. Frontiers in Aging Neuroscience. 6. 162–162. 26 indexed citations
12.
Grizzell, J. Alex, et al.. (2014). Cotinine reduces depressive-like behavior, working memory deficits, and synaptic loss associated with chronic stress in mice. Behavioural Brain Research. 268. 55–65. 56 indexed citations
13.
Grizzell, J. Alex, et al.. (2014). Cotinine reduces depressive-like behavior and hippocampal vascular endothelial growth factor downregulation after forced swim stress in mice.. Behavioral Neuroscience. 128(6). 713–721. 19 indexed citations
14.
Echeverrı́a, Valentina & Alexandre Iarkov. (2013). Potential Mechanisms Underlying the Facilitation of Fear Memory Extinction by Cotinine. British Journal of Medicine and Medical Research. 4(2). 1 indexed citations
15.
Kim, Seung-Jae, et al.. (2010). Repetetive hindlimb movement using intermittent adaptive neuromuscular electrical stimulation in an incomplete spinal cord injury rodent model. Experimental Neurology. 223(2). 623–633. 13 indexed citations
16.
O’Neill, Derek, et al.. (2010). Characteristics and Organization of Discharge Properties in Rat Hindlimb Motoneurons. Journal of Neurophysiology. 104(3). 1549–1565. 33 indexed citations
17.
Kim, Seung-Jae, Matthew Fairchild, Alexandre Iarkov, James J. Abbas, & Ranu Jung. (2008). Adaptive Control of Movement for Neuromuscular Stimulation-Assisted Therapy in a Rodent Model. IEEE Transactions on Biomedical Engineering. 56(2). 452–461. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026